+26.4%
AZN vs SBAC
-11.3%
+37.7%
-27.9%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | SBAC | Excess | Alpha |
|---|---|---|---|---|
| 1D | +1.7% | -2.8% | +4.6% | +2.3% |
| 7D | -3.1% | -5.3% | +2.2% | -2.1% |
| 30D | +0.6% | +0.4% | +0.2% | +0.5% |
| 3M | -10.8% | -11.9% | +1.1% | -8.6% |
| 6M | -18.1% | -4.5% | -13.7% | -17.8% |
| YTD | -12.3% | -4.3% | -7.9% | -12.0% |
| 1Y | -0.2% | -3.9% | +3.7% | -0.1% |
| All | +26.4% | -11.3% | +37.7% | +30.5% |
Cumulative growth
Daily Returns
Daily percentage return beside SBAC.
Daily Out/Under-Performance
Portfolio return minus SBAC return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × SBAC return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded SBAC wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling